-- Premium Brands Holdings (PBH.TO) 公布第一季度调整后盈利和营收均有所增长，并宣布派发第二季度股息。该公司维持了2026年销售额和调整后EBITDA的预期范围，同时重申预计将超额完成其五年计划。 该公司还维持了2026年销售额和调整后EBITDA的预期范围，并重申预计将超额完成其五年计划中设定的2027年销售额和调整后EBITDA目标，分别为100亿加元和10亿加元。 第一季度持续经营业务的调整后每股收益为0.83加元，而去年同期为0.70加元。FactSet的普遍预期为0.73加元，但去年同期为0.68加元。持续经营业务的调整后盈利为4260万美元，而去年同期为3130万美元。 第一季度持续经营业务收入为20.5亿加元，而去年同期为16.5亿加元。 展望未来，公司重申预计将超过其五年计划中设定的2027年销售额100亿美元和调整后EBITDA 10亿美元的目标。 公司董事会批准派发2026年第二季度现金股息，每股0.85加元，将于2026年7月15日支付给截至2026年6月30日营业结束时登记在册的股东。该股息与上一季度持平。 “我们对本季度在实现长期业务目标方面取得的进展感到满意，并仍然处于非常有利的位置，能够达到甚至超越我们2026年的目标。本季度，我们继续利用近期产能扩张来支持新的销售举措，包括与一位重要客户成功开展全国性产品发布。此外，我们在多个新生产设施的运营效率提升方面也取得了显著进展，这些因素共同促成了本季度创纪录的财务业绩，”总裁兼首席执行官乔治·帕莱奥洛古 (George Paleologou) 表示。 帕莱奥洛古补充道：“我们也很高兴在本季度完成了对 Stampede Culinary Partners 的收购。Stampede 的整合工作进展顺利，我们正与其领导团队紧密合作，推进多项增长和协同效应计划，以提升其运营和财务业绩。” “本季度结束后，我们完成了出售所持有的Shaw Bakers 74%股份的交易，净收益约为1.6亿美元。此次交易是我们非核心投资变现战略的第一步，我们预计最终将从中获得超过10亿美元的净收益。 “在收购方面，我们正在评估几个有吸引力的机会，但任何交易都将以持续增强我们的财务实力为目标。” PBH的股票昨日在加拿大上涨了2.5%。
Related Articles
Australia
CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says
CVS Health (CVS) is increasingly more likely to reach its 3% Medicare Advantage target margin in 2028, RBC Capital Markets analyst said in a note Wednesday.Analysts said the company's Q1 adjusted earnings "comfortably" beat expectations, driven by "strong" topline growth and a notable improvement in profitability in the Health Care Benefits segment.Medical costs came in below expectations and, while the company maintained its medical benefit ratio guidance for the year, it is increasingly likely to outperform, according to the note.The brokerage raised its 2026 adjusted earnings estimate for the company to $7.41 from $7.10. Analysts surveyed by FactSet expect $7.29.RBC reiterated its outperform rating on the stock and increased its price target to $107 from $93.Price: $87.01, Change: $+0.14, Percent Change: +0.17%
$CVS
Research
Research Alert: CFRA Maintains Strong Buy Rating On Shares Of Trimble Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price to $86, from 85, on a forward P/E of 21x our 2027 EPS projection of $4.08, below historical averages. We increase our 2026 EPS projection to $3.59 from $3.52, and lift our 2027 EPS estimate to $4.08 from $4.06. TRMB reported solid Q1 beats with revenue of $939.9M, up 12% Y/Y, led by AECO at 14% organic revenue and ARR growth, Field Systems posting 12% growth, and Transportation & Logistics growing 7% despite freight market headwinds. ARR reached a record $2.435B, up 13% organically, reinforcing business model durability. Non-GAAP operating margin improved 230 bps to 25.9%, while non-GAAP gross margins expanded 180 bps to 71.0%, and we see continued margin expansion as its subscription revenues scale. We note steady execution in its core business, while building AI momentum through new products and partnerships with AI labs. Management reaffirmed its 2027 targets, supporting our positive view, though macro risks warrant monitoring.
$TRMB
Australia
Apollo Global Trades at Lower Discount Versus Peers, RBC Says
Apollo Global Management (APO) shares are trading in-line with historical average multiple and at a lower discount against its peers, RBC Capital Markets said in a Thursday note."We maintain our Sector Perform rating largely driven by relative valuation," the report said.The note said its Q1 performance was characterized by strong fee-related earnings growth, offset by weak spread-related earnings growth, driving a low adjusted net income per share growth.RBC raised its price target to $146 from $139 on rolling forward its valuation and higher estimates.Price: $127.33, Change: $-2.20, Percent Change: -1.70%
$APO